adamis pharmaceuticals corporation 10 - k exhibit 10. 43 license agreement between adamis pharmaceuticals corporation and the regents of the university of california and dana - farber cancer institute, inc. for uc case no. sd2000 - 051 and dfci case no. 595 rmm 022411 ; 2000 - 051 / dfci table of contents recitals 1 article 1 : definitions 2 article 2 : grant 4 article 3 : consideration 5 article 4 : reports, records and payments 9 article 5 : patent matters 12 article 6 : governmental matters 15 article 7 : termination or expiration of agreement 16 article 8 : limited warranty and indemnification 17 article 9 : use of names and trademarks 19 article 10 : miscellaneous provisions 20 exhibit a : dana farber terms & conditions for licenses 24 rmm 022411 ; 2000 - 051 / dfci license agreement this agreement ( “ agreement ” ) is made by and between adamis pharmaceuticals corporation, a delaware corporation having an address at 2658 del mar heights rd. # 555, del mar, ca 92014 ( “ licensee ” ) the regents of the university of california, a california corporation having its statewide administrative offices at 1111 franklin street, oakland, california # # # - # # # - # # # # ( “ university ” ), represented by its san diego campus having an address at university of california, san diego, technology transfer office, mail code 0910, 9500 gilman drive, la jolla, california 92093 - 0910 ( “ ucsd ” ) and dana - farber cancer institute, inc, a massachusetts non - profit corporation having its offices at 450 brookline avenue, boston, massachusetts 02215 ( “ dfci ” ). this agreement is effective on the date of the last signature ( “ effective date ” ). recitals whereas, the inventions disclosed in ucsd disclosure docket no. sd2000 - 051 and titled “ telomerase reverse transcriptase as antigen for immunization in cancer ” ( “ ucsd invention ” ), were made in the course of research at ucsd by dr. maurizio zanetti ( hereinafter, the “ ucsd inventor ” ) and are covered by patent rights as defined below ; whereas, the inventor is an employee of ucsd, and he is obligated to assign all of his right, title and interest in the invention to university ; whereas,